HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Parul Kamboj Selected Research

isoacteoside

12/2021Evaluation of therapeutic effect of Premna herbacea in diabetic rat and isoverbascoside against insulin resistance in L6 muscle cells through bioenergetics and stimulation of JNK and AKT/mTOR signaling cascade.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Parul Kamboj Research Topics

Disease

5Insulin Resistance
12/2023 - 12/2021
4Acne Vulgaris
03/2024 - 10/2016
4Obesity
12/2023 - 12/2021
3Fatty Liver
01/2023 - 01/2021
2Non-alcoholic Fatty Liver Disease
02/2024 - 01/2023
2Inflammation (Inflammations)
02/2024 - 11/2023
2Metabolic Diseases (Metabolic Disease)
12/2023 - 01/2021
2Metabolic Syndrome (Dysmetabolic Syndrome X)
12/2023 - 01/2021
1Bullous Pemphigoid (Pemphigoid)
01/2024
1Fibrosis (Cirrhosis)
11/2023
1Body Weight (Weight, Body)
11/2023
1Dyslipidemias (Dyslipidemia)
11/2023
1Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal)
06/2023
1Weight Gain
01/2023
1Glucose Intolerance
01/2023
1Alcoholic Fatty Liver
01/2023
1Pemphigus (Pemphigus Vulgaris)
03/2022
1Type 2 Diabetes Mellitus (MODY)
12/2021
1Disease Progression
01/2021
1Alopecia (Baldness)
07/2019
1Neoplasms (Cancer)
07/2019
1Allergic Contact Dermatitis
06/2019
1Contact Dermatitis (Eczema, Contact)
06/2019
1Eczema
06/2019
1Skin Diseases (Skin Disease)
06/2019

Drug/Important Bio-Agent (IBA)

3Triglycerides (Triacylglycerol)IBA
02/2024 - 11/2023
3Glucose (Dextrose)FDA LinkGeneric
12/2023 - 01/2023
3FructoseIBA
12/2023 - 01/2021
3Insulin (Novolin)FDA Link
11/2023 - 01/2023
3LipidsIBA
11/2023 - 12/2021
2Peroxisome Proliferator-Activated Receptors (PPAR)IBA
03/2024 - 12/2021
2Blood Glucose (Blood Sugar)IBA
12/2023 - 01/2021
2Plant ExtractsIBA
12/2023 - 01/2021
2saroglitazarIBA
11/2023 - 12/2021
2Metformin (Glucophage)FDA LinkGeneric
06/2023 - 01/2021
1Messenger RNA (mRNA)IBA
03/2024
1Isotretinoin (Accutane)FDA LinkGeneric
03/2024
1Androgen Receptors (Androgen Receptor)IBA
03/2024
1Transcription Factors (Transcription Factor)IBA
03/2024
1Hydroxyproline (4 Hydroxyproline)IBA
02/2024
1Ethanol (Ethyl Alcohol)IBA
02/2024
1Bendamustine HydrochlorideFDA Link
01/2024
1Nonesterified Fatty Acids (NEFA)IBA
12/2023
1indoleIBA
12/2023
1Amino AcidsFDA Link
12/2023
1AcetylgalactosamineIBA
12/2023
1Ayush 64IBA
11/2023
1Fatty Acids (Saturated Fatty Acids)IBA
11/2023
1Phospholipids (Phosphatides)FDA LinkGeneric
11/2023
1SphingolipidsIBA
11/2023
1Palmitic Acid (Hexadecanoic Acid)IBA
11/2023
1Glycerophospholipids (Phosphoglycerides)IBA
11/2023
1Testosterone (Sustanon)FDA Link
06/2023
1FatsIBA
01/2023
1Biomarkers (Surrogate Marker)IBA
01/2023
1Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA
01/2023
1Pilocarpine (Ocusert)FDA LinkGeneric
03/2022
1Cholinergic Agents (Cholinergics)IBA
03/2022
1Ophthalmic Solutions (Eye Drops)IBA
03/2022
1PhytochemicalsIBA
12/2021
1isoacteosideIBA
12/2021
1Mitogen-Activated Protein Kinase 8IBA
12/2021
1Therapeutic UsesIBA
12/2021
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
07/2019
1Doxorubicin (Adriamycin)FDA LinkGeneric
07/2019
1Irritants (Vesicants)IBA
06/2019
1Filaggrin ProteinsIBA
06/2019
1Insulin-Like Growth Factor I (IGF-1)IBA
10/2016
1Insulin-Like PeptidesIBA
10/2016

Therapy/Procedure

1Aftercare (After-Treatment)
03/2024
1Oral Administration
11/2023
1Therapeutics
12/2021
1Drug Therapy (Chemotherapy)
07/2019